Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma
- Takeshi Hara
- , Hisashi Tsurumi
- , Naoe Goto
- , Jun Ichi Kitagawa
- , Nobuhiro Kanemura
- , Takeshi Yoshikawa
- , Senji Kasahara
- , Hideko Goto
- , Kenji Fukuno
- , Toshiki Yamada
- , Michio Sawada
- , Ichiro Yasuda
- , Naoki Katsumura
- , Takeshi Takahashi
- , Tsuyoshi Takami
- , Hisataka Moriwaki
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
19
リンクは新しいタブで開きます
被引用数
(Scopus)